Browsing byAuthorDua, K

Jump to a point in the index:
Showing results 1 to 20 of 296  next >
Issue DateTitleAuthor(s)
2021-12Natural products in the management of obesity: Fundamental mechanisms and pharmacotherapyChan, Y; Ng, SW; Tan, JZX; Gupta, G; Negi, P; Thangavelu, L; Balusamy, SR; Perumalsamy, H; Yap, WH; Singh, SK; Caruso, V; Dua, K; Chellappan, DK
2021-10-05Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro.Mehta, M; Malyla, V; Paudel, KR; Chellappan, DK; Hansbro, PM; Oliver, BG; Dua, K
2021-10-01Can dextran-based nanoparticles mitigate inflammatory lung diseases?Prasher, P; Sharma, M; R Wich, P; Jha, NK; Singh, SK; Chellappan, DK; Dua, K
2021-10Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an updateKrishnan, S; Thirunavukarasu, A; Jha, NK; Gahtori, R; Roy, AS; Dholpuria, S; Kesari, KK; Singh, SK; Dua, K; Gupta, PK
2021-10Peptides-based therapeutics: emerging potential therapeutic agents for COVID-19Shah, JN; Guo, G-Q; Krishnan, A; Ramesh, M; Katari, NK; Shahbaaz, M; Abdellattif, MH; Singh, SK; Dua, K
2021-09-13A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations.Joshi, D; Sharma, I; Gupta, S; Singh, TG; Dhiman, S; Prashar, A; Gulati, M; Kumar, B; Vishwas, S; Chellappan, DK; Gupta, G; Jha, NK; Gupta, PK; Negi, P; Dua, K; Singh, SK
2021-09Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspectiveChan, Y; Ng, SW; Singh, SK; Gulati, M; Gupta, G; Chaudhary, SK; Hing, GB; Collet, T; MacLoughlin, R; Löbenberg, R; Oliver, BG; Chellappan, DK; Dua, K
2021-09Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: A HypothesisKaur, J; Gulati, M; Gowthamarajan, K; Vishwas, S; Kumar Chellappan, D; Gupta, G; Dua, K; Pandey, NK; Kumar, B; Singh, SK
2021-09Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospectsGulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H
2021-08A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnosticsAnand, K; Vadivalagan, C; Joseph, JS; Singh, SK; Gulati, M; Shahbaaz, M; Abdellattif, MH; Prasher, P; Gupta, G; Chellappan, DK; Dua, K
2021-08Overview of key molecular and pharmacological targets for diabetes and associated diseasesShahcheraghi, SH; Aljabali, AAA; Al Zoubi, MS; Mishra, V; Charbe, NB; Haggag, YA; Shrivastava, G; Almutary, AG; Alnuqaydan, AM; Barh, D; Dua, K; Chellappan, DK; Gupta, G; Lotfi, M; Serrano-Aroca, Á; Bahar, B; Mishra, YK; Takayama, K; Panda, PK; Bakshi, HA; Tambuwala, MM
2021-08Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of careAljabali, AAA; Pal, K; Serrano-Aroca, A; Takayama, K; Dua, K; Tambuwala, MM
2021-08Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseasesShastri, MD; Allam, VSRR; Shukla, SD; Jha, NK; Paudel, KR; Peterson, GM; Patel, RP; Hansbro, PM; Chellappan, DK; Dua, K
2021-08Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseasesMehta, M; Paudel, KR; Shukla, SD; Allam, VSRR; Kannaujiya, VK; Panth, N; Das, A; Parihar, VK; Chakraborty, A; Ali, MK; Jha, NK; Xenaki, D; Su, QP; Wich, PR; Adams, J; Hansbro, PM; Chellappan, DK; Oliver, BGG; Dua, K
2021-08Development of mushroom polysaccharide and probiotics based solid self-nanoemulsifying drug delivery system loaded with curcumin and quercetin to improve their dissolution rate and permeability: State of the artKhursheed, R; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Jain, SK; Gowthamarajan, K; Zacconi, F; Chellappan, DK; Gupta, G; Jha, NK; Gupta, PK; Dua, K
2021-07-28Targeting Cellular Signalling Pathways in Lung DiseasesDua, K; Löbenberg, R; Luzo, ACM; Shukla, S; Satija, S
2021-07-20Nanovaccine: A hope to triumph the battle against novel Coronavirus disease 2019 (COVID-19).Singh, A; Maurya, A; Mishra, G; Awasthi, R; Dua, K; Kulkarni, G
2021-07-01Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK
2021-07-01CRISPR-Cas9 gene editing: New hope for Alzheimer's disease therapeuticsBhardwaj, S; Kesari, KK; Rachamalla, M; Mani, S; Ashraf, GM; Jha, SK; Kumar, P; Ambasta, RK; Dureja, H; Devkota, HP; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Ruokolainen, J; Kamal, MA; Ojha, S; Jha, NK
2021-07Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment StrategiesAlnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK